Business Context and Reporting Period
This Form 8-K is a current report filed by Ra Medical Systems, Inc. (now Catheter Precision, Inc.) on August 1, 2023. The filing announces a corporate name change and a corresponding change in the company's stock ticker symbol on the NYSE American.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Corporate Name: The company changed its name from Ra Medical Systems, Inc. to Catheter Precision, Inc. via a certificate of amendment filed on August 1, 2023, effective August 17, 2023.
- Trading Symbol: The ticker symbol on the NYSE American changed from RMED to VTAK.
- Trading Commencement: Trading under the new symbol is anticipated to begin on August 18, 2023.
- CUSIP Number: The company does not anticipate a change to its CUSIP number, though this is subject to final determination by the CUSIP Bureau.
Guidance, Outlook, and Risks
Management provided forward-looking statements regarding the timing of the ticker symbol change and the potential issuance of a new CUSIP number. These outcomes are contingent upon actions by the NYSE American and the CUSIP Bureau. The filing notes that actual results may differ materially from expectations due to these external dependencies. Investors are directed to the company's Form 10-K and Form 10-Q for a comprehensive list of risk factors.
Investor Verification Checklist
- Confirm the effective date of the name change (August 17, 2023) and the start date for trading under the new ticker VTAK (August 18, 2023).
- Verify whether the CUSIP number remains unchanged or if a new one is assigned by the CUSIP Bureau.
- Review the company's recent Form 10-K and Form 10-Q for underlying financial health and risk factors not detailed in this 8-K.